Markets:

Overview

News

Currencies

International

Treasuries

Septerna, Inc. - Common Stock (NQ:SEPN)

47.75 -0.13 (-0.27%)

Delayed Quote Updated: 3:36 PM EST, Nov 5, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Septerna, Inc. - Common Stock

< Previous 1 2 Next >

Septerna's Chief People Officer Sold Nearly 12,000 Company Shares. What Does That Mean for Investors? ↗

July 05, 2026

Septerna, a clinical-stage biotech focused on GPCR-targeted therapies, reported significant insider selling in its latest SEC filing.

Via The Motley Fool

Topics Regulatory Compliance

Is Septerna a Stock to Sell After an Insider Let Go of 15,000 Shares? ↗

June 29, 2026

This clinical-stage biotech focused on GPCR-targeted therapies reported a notable insider sale amid rapid share price appreciation.

Via The Motley Fool

Topics Regulatory Compliance

Novo Nordisk’s Akero Therapeutics Buy Targets Eli Lilly’s Lead ↗

October 15, 2025

Novo Nordisk’s $4.7B Akero deal boosts its metabolic health pipeline, targeting Eli Lilly’s lead in obesity and liver disease treatments

Via MarketBeat

Topics World Trade

Analyst Flags Septerna As Undervalued Biotech Play With Significant Upside ↗

June 23, 2025

Septerna gains Buy rating as HC Wainwright highlights undervaluation, strong pipeline, and key partnership with Novo Nordisk in metabolic diseases.

Via Benzinga

This Ventas Analyst Turns Bullish; Here Are Top 5 Upgrades For Monday ↗

June 23, 2025

Via Benzinga

This Hilton Worldwide Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday ↗

June 23, 2025

Via Benzinga

The Analyst Verdict: Septerna In The Eyes Of 4 Experts ↗

June 23, 2025

Via Benzinga

Novo Nordisk Is Shedding Muscle In The Weight-Loss Brawl With Eli Lilly ↗

May 29, 2025

Eli Lilly is rapidly encroaching on Novo Nordisk's yearslong lead in GLP-1 drugs. Can Novo hold its tentpole position?

Via Investor's Business Daily

Analysts Think These Stocks Could More Than Double in Value

May 23, 2025

Septerna, Intellia, and Novavax have garnered investor attention for their significant upside potential, but investors should beware the risks as well.

Via MarketBeat

Topics World Trade

Where Septerna Stands With Analysts ↗

May 16, 2025

Via Benzinga

3 Stocks That Will Profit From Trump's Drug Price Cut ↗

May 16, 2025

Trump's EO aims to lower US drug prices by using leverage of public programs (like Medicare) to force accountability. Big pharma may be hit hardest.

Via Benzinga

Topics Government

Ozempic Maker Novo Nordisk Looks For New Chief, Jørgensen Steps Down From CEO Role ↗

May 16, 2025

Novo Nordisk CEO steps down after pressure from shareholders. Former CEO to join board as observer. Company remains optimistic amid mixed signals.

Via Benzinga

Which stocks have an unusual volume on Thursday? ↗

May 15, 2025

Let's have a look at what is happening on the US markets on Thursday. Below you can find the stocks with an unusual volume in today's session.

Via Chartmill

Is It Time to Buy the Dip in Novo Nordisk Stock?

May 15, 2025

Novo Nordisk stock is down nearly 50% in 2025 as competition in the GLP-1 space continues to mount, but the fundamental case for the NVO stock is growing

Via MarketBeat

Topics Government

Top movers analysis in the middle of the day on 2025-05-14: top gainers and losers in today's session. ↗

May 14, 2025

Curious about what's happening in today's session? Check out the latest stock movements and price changes.

Via Chartmill

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

May 14, 2025

Via Benzinga

Let's uncover which stocks are experiencing notable gaps during today's session. ↗

May 14, 2025

Let's have a look at what is happening on the US markets on Wednesday. Below you can find the gap up and gap down stocks in today's session.

Via Chartmill

Dow Edges Higher; US Crude Oil Inventories Increase ↗

May 14, 2025

Via Benzinga

Topics Stocks

Wednesday's pre-market session: top gainers and losers ↗

May 14, 2025

Before the opening bell on Wednesday, let's take a glimpse of the US markets and explore the top gainers and losers in today's pre-market session.

Via Chartmill

Novo Nordisk Inks $2.2 Billion Deal With Septerna To Develop Oral Weight Loss And Diabetes Drugs ↗

May 14, 2025

Novo Nordisk and Septerna enter $2.2 billion deal to develop oral small-molecule therapies targeting obesity, diabetes, and cardiometabolic diseases.

Via Benzinga

Nasdaq Gains Over 100 Points; Sony Group Posts Upbeat Earnings ↗

May 14, 2025

Via Benzinga

Novo Nordisk Inks A Major Obesity Deal, Sending Shares Of New Partner Septerna Skyrocketing ↗

May 14, 2025

The deal is worth up to $2.2 billion, including more than $200 million in upfront and near-term payments.

Via Investor's Business Daily

Novo Nordisk Inks $2.2B Deal With Septerna: Retail’s Thrilled ↗

May 14, 2025

Septerna CEO Jeffrey Finer said that the collaboration allows the company to create multiple oral medicines and provides the operational flexibility and resources to advance its portfolio of other...

Via Stocktwits

Topics Artificial Intelligence

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

May 14, 2025

Via Benzinga

Why Rubrik Shares Are Trading Higher By Over 20%; Here Are 20 Stocks Moving Premarket ↗

March 14, 2025

Via Benzinga

Let's have a look at the top gainers and losers one hour before the close of the markets of today's session. ↗

February 18, 2025

Let's have a look at what is happening on the US markets one hour before the close of the markets on Tuesday. Below you can find the top gainers and losers in today's session.

Via Chartmill

Crude Oil Gains 1.5%; Fluor Shares Plunge Following Downbeat Earnings ↗

February 18, 2025

Via Benzinga

Which stocks are moving on Tuesday? ↗

February 18, 2025

Wondering how the US markets performed in the middle of the day on Tuesday? Discover the movers and shakers of today's session in our comprehensive analysis.

Via Chartmill

Tuesday's session: gap up and gap down stocks ↗

February 18, 2025

In today's session, there are notable price gaps in the US markets on Tuesday. Take a closer look at the stocks that are gap up and gap down.

Via Chartmill

US Stocks Mixed; NY State Business Activity Rises In February ↗

February 18, 2025

Via Benzinga

< Previous 1 2 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.